조산아 기관지폐이형성증의 발생에서 호산구 활성화 표지자
Eosinophil activation markers in blood and urine in preterms developing bronchopulmonary dysplasia
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Eosinophil-derived neurotoxin (EDN) is not the only a marker for eosinophil activation, but also acts as an alarm protein. Very few studies have examined the potential role of eosinophils in the development of bronchopulmonary dysplasia (BPD). This study aims to address the roles of eosinophil and EDN in the early phase of BPD development. Methods: Patients were preterm neonates with respiratory distress syndrome (RDS) born at 36 weeks of gestation or less. Blood and urine samples were collected to measure total eosinophil count in the blood, serum eosinophil cationic protein (ECP), serum EDN, and urinary EDN during the first week of life. Results: Fifty-two preterms were recruited, of whom 43 infants were analyzed. Comparisons were made between the RDS (n=16) and non-RDS groups (n=27) and between the BPD (n=6) and non-BPD groups (n=26). There were no differences between RDS and non-RDS group in total eosinophil count, serum ECP, serum EDN, or urinary EDN, except when compared by gestational age, birth weight and prenatal dexamethasone use. Urinary EDN was increased significantly in the BPD group compared to the non-BPD group. Conclusion: We demonstrated the roles of eosinophil and EDN in the development of BPD and suggest that urinary EDN may be utilized as a noninvasive factor predicting the development of BPD.
Abstract
Purpose: Eosinophil-derived neurotoxin (EDN) is not the only a marker for eosinophil activation, but also acts as an alarm protein. Very few studies have examined the potential role of eosinophils in the development of bronchopulmonary dysplasia (BPD). This study aims to address the roles of eosinophil and EDN in the early phase of BPD development. Methods: Patients were preterm neonates with respiratory distress syndrome (RDS) born at 36 weeks of gestation or less. Blood and urine samples were collected to measure total eosinophil count in the blood, serum eosinophil cationic protein (ECP), serum EDN, and urinary EDN during the first week of life. Results: Fifty-two preterms were recruited, of whom 43 infants were analyzed. Comparisons were made between the RDS (n=16) and non-RDS groups (n=27) and between the BPD (n=6) and non-BPD groups (n=26). There were no differences between RDS and non-RDS group in total eosinophil count, serum ECP, serum EDN, or urinary EDN, except when compared by gestational age, birth weight and prenatal dexamethasone use. Urinary EDN was increased significantly in the BPD group compared to the non-BPD group. Conclusion: We demonstrated the roles of eosinophil and EDN in the development of BPD and suggest that urinary EDN may be utilized as a noninvasive factor predicting the development of BPD.
참고문헌 (19)
- Allen J, "Statement on the care of the child with chronic lung disease of infancy and childhood", Am J Respir Crit Care Med, 168, pp.356~396 (2003)
- Baraldi E, "Chronic lung disease after premature birth", N Engl J Med, 357, pp.1946~1955 (2007)
- Walsh MC, "Summary proceedings from the bronchopulmonary dysplasia group", Pediatrics, 117(3 Pt 2), pp.S52~S56 (2006)
- Ehara A, "Time-course changes of eosinophil counts in premature infants : no effects of medical manipulation, except erythropoietin treatment, on eosinophilia", Pediatr Int, 42, pp.58~60 (2000)
- Smith JB, "Fetal neutrophils and eosinophils express normal levels of L-selectin", Pediatr Res, 34, pp.253~257 (1993)
- Juul SE, "Evaluation of eosinophilia in hospitalized preterm infants", J Perinatol, 25, pp.182~188 (2005)
- Moshfegh A, "Neonatal eosinophils possess efficient Eotaxin", IL-5-and N-formyl-methionyl-leucyl-phenylalanine-induced transmigration in vitro, 2005, pp.58, 138~142
- Raghavender B, "Eosinophil cationic protein in tracheal aspirates of preterm infants with bronchopulmonary dysplasia", J Pediatr, 130, pp.944~947 (1997)
- Yamamoto C, "Eosinophilia in premature infants : correlation with chronic lung disease", Acta Paediatr, 85, pp.1232~1235 (1996)
- Brostrom EB, "Eosinophil activation in preterm infants with lung disease", Acta Paediatr, 96, pp.23~28 (2007)
- Rosenberg HF, "Eosinophil-derived neurotoxin", RNase 2 : connecting the past, the present and the future, 2008, pp.9, 135~140
- Wennergren G, "Inflammatory mediators in blood and urine", Paediatr Respir Rev, 1, pp.259~265 (2000)
- Venge P, "Monitoring the allergic inflammation", Allergy, 59, pp.26~32 (2004)
- Iacobelli S, "Factors affecting postnatal changes in serum creatinine in preterm infants with gestational age <32 weeks", J Perinatol, 29, pp.232~236 (2009)
- Koller DY, "Sampling methods : urine", blood analysis, 2000, pp.162(2 Pt 2), S31~S33
- Yen JM, "Eosinophilia in very low birth weight infants", Pediatr Neonatol, 51, pp.116~123 (2010)
- 양주윤, "The relationship between eosinophilia and bronchopulmonary dysplasia in premature infants at less than 34 weeks’ gestation", Clinical and Experimental Pediatrics, 57(4), pp.171~177 (2014), 대한소아청소년과학회
- Kandasamy J, "Serum eotaxin-1 is increased in extremely-low-birth-weight infants with bronchopulmonary dysplasia or death", Pediatr Res, 78, pp.498~504 (2015)
- Yang D, "Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses", J Exp Med, 205, pp.79~90 (2008)